Flad Architects

Amgen opened a 245,000-sf R&D center in South San Francisco in October of 2022. Located on the Gateway of Pacific life sciences campus in Oyster Point, the leased facility was designed by Flad Architects and developed by BioMed Realty. Featuring modular wet and molecular labs, the nine-story tower accommodates Amgen's research programs in oncology, inflammation, and cardiometabolic diseases. Flexible floor plates integrate lab and office functions, with open work spaces and movable furnishings promoting collaboration and interaction.

New York’s largest healthcare provider is adapting to evolving research demands by making its Feinstein Institutes for Medical Research more conducive to the needs of today’s researchers and those hired in the future, by increasing lab capacity and efficiency, upgrading infrastructure, repurposing underutilized space, and incorporating flexibility to accommodate facility modifications for many years. The renovation is the beginning of a multi-faceted approach to support the institute’s strategy for growth.

AbbVie opened a 480,000-sf biomedical research center in South San Francisco in April of 2022. Offering state-of-the-art laboratories and collaborative workspaces, the leased facility will accelerate the discovery and commercialization of new cancer therapeutics. As the anchor tenant for the Gateway of Pacific’s first phase of construction, AbbVie occupies 11 contiguous floors in the 12-story structure.

Texas Biomedical Research Institute broke ground in December of 2021 on a $15 million nonhuman primate complex in San Antonio. Part of the Southwest National Primate Research Center, the four-building expansion will feature three large structures offering indoor and outdoor housing environments. An 18,000-sf animal care facility will provide a state-of-the-art veterinary clinic, pathology labs, and a staff meeting hub.

The Centers for Disease Control and Prevention (CDC) will begin construction in early 2021 on the 160,000-sf High Containment Continuity Laboratory in Atlanta. Designed by a joint venture of Flad Architects and Page, the BSL-4 facility will support the CDC's mission to rapidly detect and mitigate public health hazards. Accommodating approximately 80 investigators, the state-of-the-art laboratory will be one of three centers in the world designed and certified to facilitate diagnostic research on specific, select viruses.